Dr. Frank Sinicrope

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.

Findings can assist care teams in predicting if someone with advanced colorectal cancer will benefit from immunotherapy.

Early onset colorectal cancer continues to steadily increase in the U.S. and other higher income countries.